0

Platelet Disorders Collection
 1-20 of 179 Articles
Letters |  2 July 2013
Successful Treatment of the Postpartum Atypical Hemolytic Uremic Syndrome With Eculizumab
Stefan Zschiedrich, MD; Eric P. Prager, MD; E. Wolfgang Kuehn, MD
Ann Intern Med. 2013;159(1):76. doi:10.7326/0003-4819-159-1-201307020-00023
Reviews |  2 January 2007
Systematic Review: Efficacy and Safety of Rituximab for Adults with Idiopathic Thrombocytopenic Purpura
Donald M. Arnold, MD, MSc; Francesco Dentali, MD; Mark A. Crowther, MD, MSc; et al.
Ann Intern Med. 2007;146(1):25-33. doi:10.7326/0003-4819-146-1-200701020-00006
Articles |  5 April 2005
Brief Communication: Duration of Platelet Dysfunction after a 7-Day Course of Ibuprofen
Neil A. Goldenberg, MD; Linda Jacobson, MT; Marilyn J. Manco-Johnson, MD
Ann Intern Med. 2005;142(7):506-509. doi:10.7326/0003-4819-142-7-200504050-00009
Reviews |  20 January 2004
Management of Adult Patients with Persistent Idiopathic Thrombocytopenic Purpura Following Splenectomy: A Systematic Review
Sara K. Vesely, PhD; Jedidiah J. Perdue, MPH; Mujahid A. Rizvi, MD, MPH; et al.
Ann Intern Med. 2004;140(2):112-120. doi:10.7326/0003-4819-140-3-200402030-00012
Articles |  16 September 2003
The Rate of Progression to Polycythemia Vera or Essential Thrombocythemia in Patients with Erythrocytosis or Thrombocytosis
Marco Ruggeri, MD; Alberto Tosetto, MD; Maurizio Frezzato, MD; et al.
Ann Intern Med. 2003;139(6):470-475. doi:10.7326/0003-4819-139-6-200309160-00009
Editorials |  21 January 2003
Thrombotic Thrombocytopenic Purpura: From the Bench to the Bedside, but Not Yet to the Community
James N. George, MD; Sara K. Vesely, PhD
Ann Intern Med. 2003;138(2):152-153. doi:10.7326/0003-4819-138-2-200301210-00018
Brief Communications |  21 January 2003
Remission of Chronic Thrombotic Thrombocytopenic Purpura after Treatment with Cyclophosphamide and Rituximab
Xinglong Zheng, MD, PhD; Arnel M. Pallera, MD; Lawrence T. Goodnough, MD; et al.
Ann Intern Med. 2003;138(2):105-108. doi:10.7326/0003-4819-138-2-200301210-00011
Brief Communications |  5 February 2002
Delayed-Onset Heparin-Induced Thrombocytopenia
Lawrence Rice, MD; Walid K. Attisha, MD; Alane Drexler, MS, RN; et al.
Ann Intern Med. 2002;136(3):210-215. doi:10.7326/0003-4819-136-3-200202050-00009
Brief Communications |  18 December 2001
Quinine-Associated Thrombotic Thrombocytopenic Purpura–Hemolytic Uremic Syndrome: Frequency, Clinical Features, and Long-Term Outcomes
Kiarash Kojouri, MD, MPH; Sara K. Vesely, PhD; James N. George, MD
Ann Intern Med. 2001;135(12):1047-1051. doi:10.7326/0003-4819-135-12-200112180-00008
Brief Communications |  2 October 2001
Delayed-Onset Heparin-Induced Thrombocytopenia and Thrombosis
Theodore E. Warkentin, MD; John G. Kelton, MD
Ann Intern Med. 2001;135(7):502-506. doi:10.7326/0003-4819-135-7-200110020-00009
Brief Communications |  15 August 2000
Anti-CD20 Chimeric Monoclonal Antibody Treatment of Refractory Immune-Mediated Thrombocytopenia in a Patient with Chronic Graft-versus-Host Disease
Voravit Ratanatharathorn, MD; Erik Carson, MD; Christopher Reynolds, MD; et al.
Ann Intern Med. 2000;133(4):275-279. doi:10.7326/0003-4819-133-4-200008150-00011
Brief Communications |  16 May 2000
Antibody Inhibitors to von Willebrand Factor Metalloproteinase and Increased Binding of von Willebrand Factor to Platelets in Ticlopidine-Associated Thrombotic Thrombocytopenic Purpura
Han-Mou Tsai, MD; Lawrence Rice, MD; Ravindra Sarode, MD; et al.
Ann Intern Med. 2000;132(10):794-799. doi:10.7326/0003-4819-132-10-200005160-00005
Brief Communications |  7 March 2000
Recombinant Human Thrombopoietin Attenuates Carboplatin-Induced Severe Thrombocytopenia and the Need for Platelet Transfusions in Patients with Gynecologic Cancer
Saroj Vadhan-Raj, MD; Claire F. Verschraegen, MD; Carlos Bueso-Ramos, MD; et al.
Ann Intern Med. 2000;132(5):364-368. doi:10.7326/0003-4819-132-5-200003070-00005
Reviews |  1 December 1998
Drug-Induced Thrombocytopenia: A Systematic Review of Published Case Reports
James N. George, MD; Gary E. Raskob, MSc; Shehla Rizvi Shah, MD; et al.
Ann Intern Med. 1998;129(11_Part_1):886-890. doi:10.7326/0003-4819-129-11_Part_1-199812010-00009
Brief Communications |  1 April 1998
Thrombotic Thrombocytopenic Purpura Associated with Ticlopidine: A Review of 60 Cases
Charles L. Bennett, MD, PhD; Peter D. Weinberg, BS; Karine Rozenberg-Ben-Dror, PharmD; et al.
Ann Intern Med. 1998;128(7):541-544. doi:10.7326/0003-4819-128-7-199804010-00004
Articles |  1 November 1997
The Pathogenesis of Venous Limb Gangrene Associated with Heparin-Induced Thrombocytopenia
Theodore E. Warkentin, MD; Leela J. Elavathil, MBBS; Catherine P.M. Hayward, MD; et al.
Ann Intern Med. 1997;127(9):804-812. doi:10.7326/0003-4819-127-9-199711010-00005
Editorials |  1 May 1997
Thrombopoietin: Platelets on Demand
Kenneth Kaushansky, MD
Ann Intern Med. 1997;126(9):731-733. doi:10.7326/0003-4819-126-9-199705010-00009
Position Papers |  15 February 1997
Diagnosis and Treatment of Idiopathic Thrombocytopenic Purpura: Recommendations of the American Society of Hematology
Ann Intern Med. 1997;126(4):319-326. doi:10.7326/0003-4819-126-4-199702150-00010
Editorials |  15 February 1997
Idiopathic Thrombocytopenic Purpura: Lessons from a Guideline
James N. George, MD; Frank Davidoff, MD, Editor
Ann Intern Med. 1997;126(4):317-318. doi:10.7326/0003-4819-126-4-199702150-00009
Ideas and Opinions |  15 February 1997
Therapy for Adults with Refractory Chronic Immune Thrombocytopenic Purpura
Robert McMillan, MD
Ann Intern Med. 1997;126(4):307-314. doi:10.7326/0003-4819-126-4-199702150-00007
Advertisement

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)